Harmony Biosciences (HRMY) Financials: Revenue & Earnings
HRMY$37.99+0.04 +0.12%
$2.21B
Market Cap
11.77
P/E
9.62
Forward P/E
74
Score
Harmony Biosciences (HRMY) Financials: Revenue & Earnings
HRMY price $37.99 +0.04 +0.12%
- Ticker
- HRMY
- Price
- $37.99
- Change
- +0.04 +0.12%
- Market cap ?
- $2.21B
- P/E ?
- 11.77
- Forward P/E ?
- 9.62
- Dividend yield ?
- 0.00%
- Beta ?
- 1.01
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 74
- Value
- 70
- Quality
- 77
- Growth
- 76
Stocklytics score rationale: value 70, quality 77, growth 76.
Financials
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0 | 5995000 | 159742000 | 305440000 | 437855000 | 582022000 | 714734000 | 868453000 |
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known…
Fair value
HRMY fair value $79.80. Price $37.99. Price is 52% below fair value.
Below fair value, around its usual discount.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 354.90M. Growth 6.24%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.85% (beta 1.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 58.24M. Net debt -512.92M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | 1.10 | — | 273.08M |
| 2026-08-04 | 1.28 | 0.96 | 261.28M | 250.77M |
| 2026-05-07 | 0.55 | 0.76 | 215.39M | 220.84M |
| 2026-02-24 | 0.38 | 0.84 | 243.78M | 240.32M |
| 2025-11-04 | 0.87 | 0.92 | 239.46M | 240.04M |
| 2025-08-05 | 0.68 | 0.78 | 200.49M | 220.16M |
| 2025-05-06 | 0.78 | 0.59 | 184.73M | 206.05M |
| 2025-02-25 | 0.85 | 0.74 | 201.27M | 183.21M |
| 2024-10-29 | 0.79 | 0.67 | 186.04M | 198.58M |
| 2024-08-06 | 0.20 | -0.06 | 172.81M | 173.10M |
| 2024-04-30 | 0.67 | 0.60 | 154.62M | 154.68M |
| 2024-02-22 | 0.45 | 0.48 | 168.41M | 169.65M |
| 2023-10-31 | 0.75 | 0.65 | 160.27M | 148.88M |
| 2023-08-01 | 0.56 | 0.63 | 134.22M | 142.03M |
| 2023-05-02 | 0.48 | 0.44 | 119.13M | 116.19M |
| 2023-02-21 | 0.79 | 0.58 | 128.31M | 127.66M |
| 2022-11-01 | 1.44 | 0.10 | 117.21M | 113.59M |
| 2022-08-02 | 0.57 | 0.40 | 107.03M | 100.73M |
| 2022-05-03 | 0.51 | 0.25 | 85.31M | 88.55M |
| 2022-02-28 | 0.38 | 0.32 | 91.21M | 89.53M |
| 2021-11-09 | 0.51 | 0.27 | 80.73M | 78.87M |
| 2021-08-10 | 0.54 | 0.19 | 73.82M | 68.90M |
| 2021-05-11 | 0.38 | 0.02 | 59.67M | 787.70M |
| 2021-03-25 | 0.25 | 0.11 | 56.29M | — |
| 2020-11-12 | -0.14 | -0.05 | 45.61M | 36.49M |
| 2020-08-20 | -0.70 | — | 19.84M | — |
| 2020-06-30 | -0.00 | — | 38.01M | — |
| 2019-12-31 | -0.66 | — | 6.00M | — |
| 2019-09-30 | -0.58 | — | — | — |
| 2019-06-30 | -0.37 | — | — | — |
| 2019-03-31 | -1.14 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Budur Kumar | Buy | 25.45K | $30.27 | 770.25K |
| 2026-09-18 | Budur Kumar | Sell | 25.45K | $30.27 | 770.25K |
| 2026-09-18 | Budur Kumar | Buy | 10.41K | $30.69 | 319.36K |
| 2026-09-18 | Budur Kumar | Sell | 10.41K | $30.69 | 319.36K |
| 2026-09-18 | Budur Kumar | Sell | 35.85K | $43.05 | 1.54M |
| 2026-09-17 | Budur Kumar | Sell | 400 | $30.27 | 12.11K |
| 2026-09-17 | Budur Kumar | Sell | 400 | $30.69 | 12.28K |
| 2026-09-17 | Budur Kumar | Buy | 400 | $30.27 | 12.11K |
| 2026-09-17 | Budur Kumar | Buy | 400 | $30.69 | 12.28K |
| 2026-09-17 | Budur Kumar | Sell | 800 | $43.00 | 34.40K |
| 2026-09-16 | Budur Kumar | Sell | 900 | $30.27 | 27.24K |
| 2026-09-16 | Budur Kumar | Sell | 900 | $30.69 | 27.62K |
| 2026-09-16 | Budur Kumar | Buy | 900 | $30.27 | 27.24K |
| 2026-09-16 | Budur Kumar | Buy | 900 | $30.69 | 27.62K |
| 2026-09-16 | Budur Kumar | Sell | 1.80K | $43.01 | 77.43K |
| 2026-09-08 | Budur Kumar | Sell | 10.75K | $30.27 | 325.52K |
| 2026-09-08 | Budur Kumar | Buy | 10.75K | $30.27 | 325.52K |
| 2026-09-08 | Budur Kumar | Sell | 12.20K | $30.69 | 374.42K |
| 2026-09-08 | Budur Kumar | Buy | 12.20K | $30.69 | 374.42K |
| 2026-09-08 | Budur Kumar | Sell | 4.50K | $42.25 | 190.11K |
| 2026-09-08 | Budur Kumar | Sell | 22.95K | $43.10 | 989.35K |
| 2026-09-08 | Budur Kumar | Sell | 1.00K | $42.79 | 42.79K |
| 2026-09-04 | Budur Kumar | Sell | 5.50K | $41.98 | 230.91K |
| 2026-07-16 | Mollichella Stephen M. | Other | 0 | — | — |
| 2026-07-16 | Mollichella Stephen M. | Other | 12.17K | $37.46 | 455.96K |
| 2026-07-16 | Mollichella Stephen M. | Other | 8.50K | $30.69 | 260.87K |
| 2026-07-16 | Mollichella Stephen M. | Other | 7.05K | $38.01 | 267.97K |
| 2026-07-16 | Mollichella Stephen M. | Other | 20.75K | $36.76 | 762.77K |
| 2026-07-16 | Mollichella Stephen M. | Other | 5.90K | — | — |
| 2026-05-14 | Germano Geno J | Buy | 21.23K | $30.76 | 653.07K |
| 2026-05-14 | Germano Geno J | Other | 0 | — | — |
| 2026-05-14 | Szyper Linda M | Buy | 21.87K | $30.76 | 672.78K |
| 2026-05-14 | Philip Ron M | Buy | 21.87K | $30.76 | 672.78K |
| 2026-05-14 | Graf R. Mark | Buy | 21.87K | $30.76 | 672.78K |
| 2026-05-14 | Sabater Juan A. | Buy | 21.87K | $30.76 | 672.78K |
| 2026-05-14 | Sender Gary | Buy | 21.87K | $30.76 | 672.78K |
| 2026-05-01 | Budur Kumar | Sell | 18.75K | — | — |
| 2026-05-01 | Budur Kumar | Buy | 18.75K | — | — |
| 2026-05-01 | Budur Kumar | Sell | 8.88K | $31.83 | 282.71K |
| 2026-04-14 | Reicin Glenn | Buy | 164.31K | $29.29 | 4.81M |
| 2026-04-14 | Reicin Glenn | Other | 0 | — | — |
| 2026-04-07 | Zaeske Adam H. | Buy | 7.50K | — | — |
| 2026-04-07 | Zaeske Adam H. | Sell | 7.50K | — | — |
| 2026-04-07 | Zaeske Adam H. | Sell | 3.17K | $27.62 | 87.64K |
| 2026-04-02 | Anastasiou Peter | Buy | 212.24K | $27.74 | 5.89M |
| 2026-04-02 | Ignelzi Troy A. | Buy | 17.71K | $27.74 | 491.28K |
| 2026-04-02 | Ignelzi Troy A. | Other | 0 | — | — |
| 2026-01-26 | Kapadia Sandip | Sell | 3.75K | $37.15 | 139.17K |
| 2026-01-25 | Kapadia Sandip | Sell | 4.72K | — | — |
| 2026-01-25 | Kapadia Sandip | Buy | 4.72K | — | — |
| 2026-01-25 | Kapadia Sandip | Sell | 2.55K | $36.82 | 94.00K |
| 2026-01-25 | Serafin Andrew | Sell | 2.60K | — | — |
| 2026-01-25 | Serafin Andrew | Buy | 2.60K | — | — |
| 2026-01-25 | Serafin Andrew | Sell | 1.13K | $36.82 | 41.46K |
| 2026-01-25 | Budur Kumar | Sell | 2.66K | — | — |
| 2026-01-25 | Budur Kumar | Buy | 2.66K | — | — |
| 2026-01-25 | Budur Kumar | Sell | 1.37K | $36.82 | 50.52K |
| 2026-01-25 | Dayno Jeffrey M. | Sell | 13.00K | — | — |
| 2026-01-25 | Dayno Jeffrey M. | Buy | 13.00K | — | — |
| 2026-01-25 | Dayno Jeffrey M. | Sell | 5.65K | $36.82 | 208.18K |
| 2026-01-24 | Kapadia Sandip | Sell | 3.81K | — | — |
| 2026-01-24 | Kapadia Sandip | Buy | 3.81K | — | — |
| 2026-01-24 | Kapadia Sandip | Sell | 2.24K | $36.82 | 82.44K |
| 2026-01-24 | Serafin Andrew | Sell | 2.50K | — | — |
| 2026-01-24 | Serafin Andrew | Buy | 2.50K | — | — |
| 2026-01-24 | Serafin Andrew | Sell | 1.12K | $36.82 | 41.09K |
| 2026-01-24 | Budur Kumar | Sell | 2.19K | — | — |
| 2026-01-24 | Budur Kumar | Buy | 2.19K | — | — |
| 2026-01-24 | Budur Kumar | Sell | 1.15K | $36.82 | 42.45K |
| 2026-01-24 | Dayno Jeffrey M. | Sell | 10.50K | — | — |
| 2026-01-24 | Dayno Jeffrey M. | Buy | 10.50K | — | — |
| 2026-01-24 | Dayno Jeffrey M. | Sell | 4.79K | $36.82 | 176.18K |
| 2026-01-22 | Kapadia Sandip | Buy | 42.60K | $36.76 | 1.57M |
| 2026-01-22 | Kapadia Sandip | Buy | 12.20K | — | — |
| 2026-01-22 | Serafin Andrew | Buy | 42.60K | $36.76 | 1.57M |
| 2026-01-22 | Serafin Andrew | Buy | 12.20K | — | — |
| 2026-01-22 | Budur Kumar | Buy | 42.60K | $36.76 | 1.57M |
| 2026-01-22 | Budur Kumar | Buy | 12.20K | — | — |
| 2026-01-22 | Zaeske Adam H. | Buy | 56.90K | $36.76 | 2.09M |
| 2026-01-22 | Zaeske Adam H. | Buy | 16.20K | — | — |
| 2026-01-22 | Dayno Jeffrey M. | Buy | 184.60K | $36.76 | 6.79M |
| 2026-01-22 | Dayno Jeffrey M. | Buy | 52.90K | — | — |
| 2026-01-15 | Kapadia Sandip | Sell | 20.96K | $35.92 | 752.83K |
| 2025-12-12 | Dayno Jeffrey M. | Buy | 20.00K | $8.22 | 164.40K |
| 2025-12-12 | Dayno Jeffrey M. | Sell | 5.93K | $40.11 | 237.96K |
| 2025-12-12 | Dayno Jeffrey M. | Sell | 20.00K | $8.22 | 164.40K |
| 2025-12-05 | Kapadia Sandip | Sell | 20.00K | $29.03 | 580.60K |
| 2025-12-05 | Kapadia Sandip | Buy | 20.00K | $29.03 | 580.60K |
| 2025-12-05 | Kapadia Sandip | Sell | 20.00K | $39.54 | 790.90K |
| 2025-11-21 | Kapadia Sandip | Sell | 3.43K | $35.00 | 119.94K |
| 2025-09-30 | Kapadia Sandip | Sell | 45.00K | — | — |
| 2025-09-30 | Kapadia Sandip | Buy | 45.00K | — | — |
| 2025-09-30 | Kapadia Sandip | Sell | 24.04K | $27.56 | 662.51K |
| 2025-08-28 | Valor IV Pharma Holdings, LLC | Sell | 6.62M | — | — |
| 2025-08-15 | Kapadia Sandip | Sell | 21.57K | $36.50 | 787.38K |
| 2025-05-25 | Graf R. Mark | Buy | 14.52K | $34.23 | 497.09K |
| 2025-05-15 | Sabater Juan A. | Buy | 14.52K | $34.23 | 497.09K |
| 2025-05-15 | Gracias Antonio J. | Buy | 14.52K | $34.23 | 497.09K |
| 2025-05-15 | Philip Ron M | Buy | 14.52K | $34.23 | 497.09K |
| 2025-05-15 | Szyper Linda M | Buy | 14.52K | $34.23 | 497.09K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 336, holders +15 vs prior quarter. Ownership 94.34%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 7.10M | 31.93K | +0.45% | 258.58M |
| FMR LLC | 3.57M | 416.48K | +13.19% | 130.13M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.88M | 166.14K | +6.12% | 104.88M |
| AMERICAN CENTURY COMPANIES INC | 2.54M | 434.33K | +20.63% | 92.46M |
| DIMENSIONAL FUND ADVISORS LP | 2.39M | 317.08K | +15.27% | 87.14M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.11M | 2.74K | +0.13% | 76.64M |
| LSV ASSET MANAGEMENT | 2.06M | 36.10K | +1.78% | 75.05M |
| STATE STREET CORP | 1.86M | 74.96K | +4.20% | 67.70M |
| ARMISTICE CAPITAL, LLC | 1.56M | -60.00K | -3.69% | 56.95M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.44M | 119.93K | +9.07% | 52.53M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.31M | -69.56K | -5.03% | 47.79M |
| RENAISSANCE TECHNOLOGIES LLC | 1.20M | 118.00K | +10.95% | 43.52M |
| TWO SIGMA INVESTMENTS, LP | 959.14K | 225.69K | +30.77% | 34.92M |
| AQR CAPITAL MANAGEMENT LLC | 934.33K | 218.08K | +30.45% | 34.02M |
| SG AMERICAS SECURITIES, LLC | 882.72K | -1.14M | -56.26% | 32.14M |
| VALOR MANAGEMENT LLC | 818.01K | 700.88K | +598.38% | 29.78M |
| MORGAN STANLEY | 733.68K | -297.33K | -28.84% | 26.71M |
| UBS GROUP AG | 602.99K | 155.00K | +34.60% | 21.95M |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 551.08K | -16.04K | -2.83% | 20.06M |
| INVESCO LTD. | 528.52K | -99.73K | -15.87% | 19.24M |
| JPMORGAN CHASE & CO | 514.09K | -309.43K | -37.57% | 18.25M |
| VENBIO PARTNERS LLC | 472.19K | -17.00K | -3.48% | 17.19M |
| NORTHERN TRUST CORP | 471.22K | 47.99K | +11.34% | 17.16M |
| BNP PARIBAS FINANCIAL MARKETS | 438.30K | -106.89K | -19.61% | 15.96M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 423.82K | 423.82K | New | 15.43M |
Earnings and financials
Harmony Biosciences Holdings, Inc. (HRMY) trades at $37.99, with a market cap of $2.21B and a trailing P/E of 11.77. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0 | 5995000 | 159742000 | 305440000 | 437855000 | 582022000 | 714734000 | 868453000 |
Insights · Dividends · Forecast · Financials · Learn